RBM10 and pancreatic neoplasm: Furthermore, whole-exome sequencing of pancreatic cancer indicated that in 75% of these cases, RBM10 mutations were associated with favorable patient prognoses, suggesting these mutations could improve the survival rate and prolong the survival period (6).